ArticleLife (Basel, Switzerland)2025
Interpreting Deep Neural Networks in Diabetic Retinopathy Grading: A Comparison with Human Decision Criteria.
Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic accuracy and clinical performance of deep learning models for grading diabetic retinopathy: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) causes visual impairment and blindness in millions of diabetic patients globally. Fundus image-based Automatic Diabetic Retinopathy Classifiers (ADRCs) can ensure regular retina checkups for many diabetic patients and reduce the burden on the limited number of retina experts by referring only those patients who require their attention. Over the last decade, numerous deep neural network-based algorithms have been proposed for ADRCs to distinguish the severity levels of DR. However, it has not been investigated whether DNN-based ADRCs consider the same criteria as human retina professionals (HRPs), i.e., whether they follow the same grading scale when making decisions about the severity level of DR, which may put the reliability of ADRCs into question. In this study, we investigated this issue by experimenting on publicly available datasets using MobileNet-based ADRCs and analyzing the output of the ADRCs using two eXplainable artificial intelligence (XAI) techniques named Gradient-weighted Class Activation Map (Grad-CAM) and Integrated Gradients (IG).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.